GENEONE LIFE SCIENCE, INC.

Press Releases GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
2,410 ^KRW	0.00%		0.00%	-15.14%

03-28	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI
03-27	GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsight \| Leading Companies - Curevo Vaccine, GeneOne Life Science, SK Bioscience, and Others	04/10/22	AQ
GeneOne Life Science : VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies	17/03/21	AQ
GeneOne Life Science : VGXI Wins Best Contract Manufacturing Organization for the 2020 Vaccine Industry Excellence Awards	02/10/20	AQ
Inovio Pharmaceuticals : VGXI Enables Rapid GMP DNA Manufacturing Timeline for Geneos Therapeutics Personalized Cancer Immunotherapy	20/05/20	AQ
Inovio Pharmaceuticals : VGXI Supports Rapid Timeline to Clinical Testing for Coronavirus Vaccine	07/04/20	AQ
GeneOne Life Science : VGXI Recognized as Best CMO Finalist for the 2020 Vaccine Industry Excellence Awards	05/03/20	AQ
GeneOne Life Science : VGXI, Inc. Establishes Pilot mRNA Manufacturing Capabilities	09/12/19	AQ
GeneOne Life Science : VGXI Selects BE&K as Design-Build Partner for New Manufacturing Facility	04/12/19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer